380 related articles for article (PubMed ID: 17079196)
81. Relative levels of the two mammalian Rad23 homologs determine composition and stability of the xeroderma pigmentosum group C protein complex.
Okuda Y; Nishi R; Ng JM; Vermeulen W; van der Horst GT; Mori T; Hoeijmakers JH; Hanaoka F; Sugasawa K
DNA Repair (Amst); 2004 Oct; 3(10):1285-95. PubMed ID: 15336624
[TBL] [Abstract][Full Text] [Related]
82. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract][Full Text] [Related]
83. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
84. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
Mimaki T; Tanaka K; Nagai A; Mino M
Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
[TBL] [Abstract][Full Text] [Related]
85. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
Negishi I; Kato G; Moriwaki S; Ishikawa O
Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
[TBL] [Abstract][Full Text] [Related]
86. Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription.
Lainé JP; Mocquet V; Bonfanti M; Braun C; Egly JM; Brousset P
DNA Repair (Amst); 2007 Sep; 6(9):1264-70. PubMed ID: 17403617
[TBL] [Abstract][Full Text] [Related]
87. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum.
Senhaji MA; Abidi O; Nadifi S; Benchikhi H; Khadir K; Ben Rekaya M; Eloualid A; Messaoud O; Abdelhak S; Barakat A
Arch Dermatol Res; 2013 Jan; 305(1):53-57. PubMed ID: 23143338
[TBL] [Abstract][Full Text] [Related]
88. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
89. The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.
Yang PW; Hsieh CY; Kuo FT; Huang PM; Hsu HH; Kuo SW; Chen JS; Lee JM
Ann Surg Oncol; 2013 Feb; 20(2):562-71. PubMed ID: 22941172
[TBL] [Abstract][Full Text] [Related]
90. [XPD (ERCC2) (Xeroderma pigmentosum, group D). Reparation gene].
Bull Cancer; 1998 Dec; 85(12):987-8. PubMed ID: 9988553
[No Abstract] [Full Text] [Related]
91. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity.
Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S
Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045
[TBL] [Abstract][Full Text] [Related]
92. Genotype-phenotype relationships in trichothiodystrophy patients with novel splicing mutations in the XPD gene.
Botta E; Nardo T; Orioli D; Guglielmino R; Ricotti R; Bondanza S; Benedicenti F; Zambruno G; Stefanini M
Hum Mutat; 2009 Mar; 30(3):438-45. PubMed ID: 19085937
[TBL] [Abstract][Full Text] [Related]
93. Loss of Function Variants in the XPC Causes Severe Xeroderma Pigmentosum in Three Large Consanguineous Families.
Nawal W; Ullah A; Ullah U; Farrakh K; Ahmad F; Khan H; Ahmad GS; Khan B; Ansar M; Kalsoom UE; Ahmad W
Klin Padiatr; 2022 May; 234(3):123-129. PubMed ID: 34544175
[TBL] [Abstract][Full Text] [Related]
94. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.
Khan SG; Yamanegi K; Zheng ZM; Boyle J; Imoto K; Oh KS; Baker CC; Gozukara E; Metin A; Kraemer KH
Hum Mutat; 2010 Feb; 31(2):167-75. PubMed ID: 19953607
[TBL] [Abstract][Full Text] [Related]
95. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
96. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
[TBL] [Abstract][Full Text] [Related]
97. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
98. XPC gene mutations in families with xeroderma pigmentosum from Pakistan; prevalent founder effect.
Ijaz A; Basit S; Gul A; Batool L; Hussain A; Afzal S; Ramzan K; Ahmad J; Wali A
Congenit Anom (Kyoto); 2019 Jan; 59(1):18-21. PubMed ID: 29569758
[TBL] [Abstract][Full Text] [Related]
99. Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs.
Fu L; Xu X; Ren R; Wu J; Zhang W; Yang J; Ren X; Wang S; Zhao Y; Sun L; Yu Y; Wang Z; Yang Z; Yuan Y; Qiao J; Izpisua Belmonte JC; Qu J; Liu GH
Protein Cell; 2016 Mar; 7(3):210-21. PubMed ID: 26874523
[TBL] [Abstract][Full Text] [Related]
100. XPC is involved in genome maintenance through multiple pathways in different tissues.
Uehara Y; Ikehata H; Furuya M; Kobayashi S; He D; Chen Y; Komura J; Ohtani H; Shimokawa I; Ono T
Mutat Res; 2009 Nov; 670(1-2):24-31. PubMed ID: 19615386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
